Emma S. Chambers

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The UK clinical eye research strategy: refreshing research priorities for clinical eye research in the UK

Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase–induced inflammation

Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol

1 <i>α</i> ,25‐dihydroxyvitamin D3 in combination with transforming growth factor‐ <i>β</i> increases the frequency of Foxp3 ⁺ regulatory T cells through preferential expansion and usage of interleukin‐2

Immunoregulatory mechanisms of vitamin D relevant to respiratory health and asthma

Vitamin D Influences Asthmatic Pathology through Its Action on Diverse Immunological Pathways

The effects of calcitriol treatment in glucocorticoid-resistant asthma

Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion

Defective IL-10 expression and in vitro steroid-induced IL-17A in paediatric severe therapy-resistant asthma

The role of 1α,25‐dihydroxyvitamin <scp>D</scp>3 and cytokines in the promotion of distinct <scp>F</scp>oxp3⁺and <scp>IL</scp>‐10⁺<scp>CD</scp>4⁺<scp>T</scp> cells

Serum 25-dihydroxyvitamin D levels correlate with CD4+Foxp3+ T-cell numbers in moderate/severe asthma